Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Cancer Pain 9Neoplasms 6Pain 4Prostatic Neoplasms 1Osteoarthritis 1Opioid-Induced Constipation 1Lymphoma, Follicular 1Inflammation 1Head and Neck Neoplasms 1Endobronchial Metastases 1Chronic Pain 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Back Pain 1Agnosia 1Acute Pain 1

Interventions

remimazolam 1Sugammadex 1Rocuronium 1Remifentanil 1Propofol 1Oxycodone 1Flumazenil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Endobronchial Metastases × Oxycodone × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡